AI 요약
semi daonil에 대한 실시간 결과 195개를 검토하고, 먼저 비교할 가치가 높은 3개의 옵션로 좁혔습니다.
이 후보 목록에서 가장 강한 주제는 Antidiabetic 및 Prescription Medicine입니다.
Compare with TopFind
라이브 검색
라이브 결과 로딩 중
TopFind가 검색어에 맞는 최신 결과를 가져오고 있습니다.
라이브 검색
TopFind가 검색어에 맞는 최신 결과를 가져오고 있습니다.
semi daonil에 대한 실시간 결과 195개를 검토하고, 먼저 비교할 가치가 높은 3개의 옵션로 좁혔습니다.
이 후보 목록에서 가장 강한 주제는 Antidiabetic 및 Prescription Medicine입니다.
출처: Sanofi-Aventis Singapore Pte Ltd
설명
Semi-Daonil is a lower-dose formulation of the antidiabetic drug Glibenclamide, containing 2.5 mg per tablet. This version is specifically designed for patients who require precise dose titration or a smaller maintenance dose to manage their Type 2 diabetes effectively without excessive risk of hypoglycemia.
추천 대상
Dosage titration, Maintenance therapy 및 Type 2 diabetes control
평점
출처: Sanofi-Aventis Singapore Pte Ltd
설명
Daonil is a prescription-only oral antidiabetic medication containing 5 mg of Glibenclamide (a sulfonylurea). It is used for the management of Type 2 diabetes mellitus to help lower blood glucose levels by stimulating the pancreas to release more insulin. It is a long-standing treatment option registered with the Health Sciences Authority (HSA) and listed on the National Drug Formulary.
추천 대상
Type 2 diabetes patients, Blood sugar management, Sulfonylurea therapy 및 Prescription medication
평점
출처: Sanofi-Aventis Singapore Pte Ltd
설명
Daonil M is a combination medication that integrates Glibenclamide with Metformin. This dual-action antidiabetic treatment targets Type 2 diabetes mellitus through two different mechanisms: increasing insulin production and improving the body's response to insulin, providing comprehensive glucose control in a single tablet.
추천 대상
Dual Action glucose control, Combination therapy 및 Type 2 diabetes management
평점
| 비교 | Semi-Daonil | Daonil | Daonil M |
|---|---|---|---|
| 출처 | Sanofi-Aventis Singapore Pte Ltd | Sanofi-Aventis Singapore Pte Ltd | Sanofi-Aventis Singapore Pte Ltd |
| 설명 | Semi-Daonil is a lower-dose formulation of the antidiabetic drug Glibenclamide, containing 2.5 mg per tablet. This version is specifically designed for patients who require precise dose titration or a smaller maintenance dose to manage their Type 2 diabetes effectively without excessive risk of hypoglycemia. | Daonil is a prescription-only oral antidiabetic medication containing 5 mg of Glibenclamide (a sulfonylurea). It is used for the management of Type 2 diabetes mellitus to help lower blood glucose levels by stimulating the pancreas to release more insulin. It is a long-standing treatment option registered with the Health Sciences Authority (HSA) and listed on the National Drug Formulary. | Daonil M is a combination medication that integrates Glibenclamide with Metformin. This dual-action antidiabetic treatment targets Type 2 diabetes mellitus through two different mechanisms: increasing insulin production and improving the body's response to insulin, providing comprehensive glucose control in a single tablet. |
| 추천 대상 | Dosage titration, Maintenance therapy 및 Type 2 diabetes control | Type 2 diabetes patients, Blood sugar management, Sulfonylurea therapy 및 Prescription medication | Dual Action glucose control, Combination therapy 및 Type 2 diabetes management |
| 작업 | |||
| 평점 |
가장 균형 잡힌 옵션부터 보고 싶다면 다음을 추천합니다:
"Semi-Daonil 출처 Sanofi-Aventis Singapore Pte Ltd."
이 항목을 선택한 이유는 Offers flexibility for healthcare providers to tailor dosage according to specific patient needs, especially during the early stages of treatment.